Nakiller Listesi

Filter by:

No. Cell source Indication Area of medicine Year Type of therapy Country Age
1 cord blood cerebral palsy neurology 2017 experimental therapy Poland 2.2
2 cord blood cerebral palsy neurology 2017 experimental therapy Poland 5.4
3 cord blood cerebral palsy neurology 2017 experimental therapy Poland 10.3
4 cord blood autism neurology 2017 experimental therapy Poland 4.11
5 cord blood CD40 ligand deficiency hematology 2017 standard therapy Turkey 9.6
6 cord blood talassemia major hematology 2017 standard therapy Turkey 4.0
7 cord blood talassemia major hematology 2017 standard therapy Turkey 4.1
8 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
9 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
10 cord blood autism neurology 2016 experimental therapy Poland 6
11 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
12 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
13 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
14 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
15 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10/12
16 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8
17 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
18 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
19 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3.5
20 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
21 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
22 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
23 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
24 cord blood histiocytosis hematology 2011 standard therapy Poland 2.5
25 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7.5
26 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1.5
27 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
28 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
29 cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1.5
30 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
31 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 67.11
32 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 47.6
33 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 56.7
34 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 48.11
35 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 46.3
36 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 45.9
37 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 75.9
38 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 51.3
39 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 59.8
40 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 64.9
41 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 56.7
42 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy olsztyn 69.10
43 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 52.0
44 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 77.2
45 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 35.6
46 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 51.6
47 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Olsztyn 46.0
48 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2.10
49 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37.9
50 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71.7
51 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland no data
52 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7.11
53 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44.1
54 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34.11
55 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58.10
56 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49.0
57 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37.4
58 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37.7
59 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26.11
60 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61.5
61 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34.1
62 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 52.9
63 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23.9
64 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31.6
65 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33.4
66 cord tissue (Wharton's jelly) tetraparesis spastica neurology 2017 experimental therapy Poland 29.4
67 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 24.9
68 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 10.6
69 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 30.0
70 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56.8
71 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65.2
72 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28.6
73 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44.2
74 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 41.4
75 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25.8
76 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 23.7
77 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43.4
78 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39.0
79 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 39.0
80 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42.11
81 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30.9
82 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 12.11
83 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 8.5
84 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 58.9
85 cord tissue (Wharton's jelly) cri du chat syndrome neurology 2017 experimental therapy Poland 8.6
86 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18.7
87 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 22.1
88 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28.11
89 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 3.1
90 cord tissue (Wharton's jelly) cranium bifidum neurology 2017 experimental therapy Poland 5.2
91 cord tissue (Wharton's jelly) transverse myelitis neurology 2017 experimental therapy Poland 8.3
92 cord tissue (Wharton's jelly) syringomielia neurology 2017 experimental therapy Poland 42.6
93 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47.2
94 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 38.5
95 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13.4
96 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 21.10
97 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5.0
98 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 41.0
99 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52.1
100 cord tissue (Wharton's jelly) cerebral palsy; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 1.9
101 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 11.11
102 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 26.10
103 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 9.1
104 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 11.5
105 cord tissue (Wharton's jelly) congenital fiber-type disproportion myopathy neurology 2017 experimental therapy Poland 1.10
106 cord tissue (Wharton's jelly) chronic myeloid leukemia hematology 2017 experimental therapy Poland 5.11
107 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61.5
108 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 40.11
109 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48.1
110 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1.11
111 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37.11
112 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 1.7
113 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 4.4
114 cord tissue (Wharton's jelly) cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 5.8
115 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 6.4
116 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15.4
117 cord tissue (Wharton's jelly) traumatic brain injury neurology 2017 experimental therapy Poland 9.4
118 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 14.1
119 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 17.11
120 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 24.9
121 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37.7
122 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31.1
123 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52.11
124 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 27.11
125 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 45.4
126 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 34.10
127 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 31.6
128 cord tissue (Wharton's jelly) hydrocephalus; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 2.3
129 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6.3
130 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7.11
131 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 3.5
132 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 6.3
133 cord tissue (Wharton's jelly) syndrom IFAP hematology 2017 experimental therapy Poland 3.5
134 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 13.0
135 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 11.10
136 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66.11
137 cord tissue (Wharton's jelly) ischemia within the optic nerve ophthalmology 2017 experimental therapy Poland 37.11
138 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35.1
139 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4.11
140 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36.11
141 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 63.11
142 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31.9
143 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 31.9
144 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10.2
145 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 33.5
146 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5.7
147 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 12.5
148 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5.9
149 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3.3
150 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 5.0
151 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1.9
152 cord tissue (Wharton's jelly) Krabbe disease neurology 2017 experimental therapy Poland 6.3
153 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24.6
154 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 45.5
155 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 31.5
156 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 48.10
157 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 62.5
158 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60.5
159 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6.1
160 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4.8
161 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6.4
162 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6.3
163 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49.1
164 cord tissue (Wharton's jelly) condition after encephalitis neurology 2017 experimental therapy Poland 19.7
165 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 35.4
166 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1.10
167 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6.8
168 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 1.5
169 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7.0
170 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13.6
171 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 6.7
172 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 32.3
173 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 46.9
174 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54.10
175 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 41.11
176 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 4.7
177 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 56.4
178 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 4.1
179 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3.6
180 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 33.4
181 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 42.1
182 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 63.2
183 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 54.11
184 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 53.9
185 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 46.9
186 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 58
187 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 55
188 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 58.1
189 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 61.7
190 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 52.6
191 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 59.11
192 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 66.9
193 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 45.1
194 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 53.4
195 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 36.1
196 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 59, 1
197 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 66.2
198 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 49.7
199 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 55.1
200 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 46.1
201 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 72.4
202 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 54.3
203 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 56.1
204 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 61.8
205 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 64.7
206 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 62.8
207 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 56.5
208 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 51.3
209 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 60.4
210 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 73.7
211 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 61.6
212 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 61.4
213 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 79.2
214 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 72.6
215 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 48.4
216 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 54.2
217 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 50.9
218 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 55.9
219 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 62.6
220 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 66.2
221 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 55.9
222 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 49.4
223 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 55.7
224 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 58.1
225 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 66.8
226 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 39.6
227 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 47.11
228 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 49.3
229 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 61.2
230 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 65.9
231 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 52.7
232 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 71.5
233 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 68.5
234 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 44.5
235 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 66.7
236 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 51.9
237 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 49.3
238 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 55.4
239 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 41.2
240 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 72.1
241 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 56.8
242 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 48.1
243 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 56.3
244 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 66.10
245 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn no data
246 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 60.8
247 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 55.5
248 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Olsztyn 53.4
249 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.11
250 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44.5
251 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60.8
252 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32.2
253 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
254 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62.5
255 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18.4
256 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48.8
257 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.3
258 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35.3
259 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53.7
260 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12.2
261 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3.10
262 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
263 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
264 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65.8
265 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2.9
266 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59.4
267 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
268 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2.11
269 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12.11
270 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9.7
271 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20.3
272 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
273 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33.5
274 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22.2
275 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.3
276 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8.5
277 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29.11
278 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33.4
279 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37.4
280 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39.3
281 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7.11
282 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
283 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69.6
284 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33.11
285 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20.7
286 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24.5
287 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25.6
288 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8.5
289 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39.10
290 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60.10
291 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6.9
292 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44.8
293 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25.4
294 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10.10
295 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19.2
296 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28.8
297 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60.9
298 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34.9
299 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69.3
300 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47.9
301 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18.8
302 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2.9
303 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54.9
304 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19.5
305 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
306 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27.9
307 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14.9
308 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42.7
309 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60.5
310 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6.2
311 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11.3
312 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9.11
313 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49.8
314 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69.9
315 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69.1
316 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13.11
317 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3.5
318 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64.2
319 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
320 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6.10
321 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2.11
322 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4.2
323 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55.4
324 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54.8
325 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33.10
326 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41.4
327 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49.3
328 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50.8
329 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63.1
330 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7.4
331 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2.11
332 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48.3
333 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32.7
334 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3.11
335 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61.11
336 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45.8
337 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6.11
338 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9.7
339 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
340 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14.7
341 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58.10
342 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12.6
343 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4.8
344 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1.5
345 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
346 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9.9
347 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6.9
348 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13.2
349 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7.4
350 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7.4
351 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
352 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38.1
353 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8.4
354 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
355 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79.8
356 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54.3
357 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14.4
358 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23.6
359 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86.5
360 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54.6
361 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68.5
362 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13.7
363 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2.2
364 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5.0
365 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12.11
366 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12.3
367 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1.3
368 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2.7
369 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3.3
370 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59.6
371 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34.2
372 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 30.3
373 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17.10
374 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37.11
375 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31.9
376 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
377 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31.9
378 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66.1
379 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60.8
380 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10.8
381 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
382 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2.11
383 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4.3
384 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
385 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59.4
386 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20.11
387 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
388 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24.5
389 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
390 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 32.3
391 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60.7
392 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1.10
393 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7.6
394 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1.10
395 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29.7
396 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
397 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9.2
398 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24.5
399 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15.9
400 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6.8
401 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10.3
402 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16.4
403 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
404 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41.8
405 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20.9
406 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5.2
407 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13.10
408 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58.4
409 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68.2
410 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54.11
411 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2.1
412 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
413 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4.1
414 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1.4
415 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14.9
416 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 3.6
417 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 70.8
418 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50.5
419 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37.7
420 cord tissue (Wharton's jelly) myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy ophthalmology 2016 experimental therapy Poland 37.1
421 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33.5
422 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16.2
423 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3.7
424 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17.9
425 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5/12
426 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57.6
427 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4.8
428 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 44.7
429 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
430 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4.4
431 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4.9
432 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28.6
433 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4.5
434 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27.2
435 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61.2
436 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44.8
437 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54.3
438 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19.2
439 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15.0
440 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31.11
441 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33.4
442 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37.3
443 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39.1
444 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38.4
445 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 44.5
446 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Poland 35.5
447 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23.4
448 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34.9
449 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Olsztyn 61.6
450 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Olsztyn 61
451 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Olsztyn 56
452 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Olsztyn 51
453 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Olsztyn 65
454 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Olsztyn 60
455 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Olsztyn 52
456 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1.4
457 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5.4
458 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23.2
459 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3.8
460 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9.6
461 cord tissue (Wharton's jelly) bilateral blindness ophthalmology 2015 experimental therapy Poland 36.10
462 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
463 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7.1
464 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15.8
465 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5.1
466 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14.5
467 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7.10
468 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
469 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7.1
470 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13.1
471 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2.4
472 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59.4
473 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31.2
474 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5.1
475 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12.5
476 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8.11
477 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3.3
478 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.5
479 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20.11
480 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18.8
481 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2.7
482 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
483 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11.11
484 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
485 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26.1
486 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37.1
487 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
488 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35.6
489 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
490 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44.6
491 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15.8
492 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.6
493 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66.2
494 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17.2
495 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45.10
496 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
497 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51.5
498 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12.10
499 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26.5
500 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
501 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4.10
502 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6.1
503 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4.6
504 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63.11
505 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32.10
506 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
507 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33.3
508 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3.6
509 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
510 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18.7
511 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24.3
512 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67.6
513 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5.6
514 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74.2
515 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37.6
516 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62.8
517 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58.10
518 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30.1
519 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
520 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1.1
521 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26.2
522 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46.2
523 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8.7
524 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8/12
525 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6.6
526 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48.7
527 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21.4
528 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9.9
529 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13.4
530 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61.3
531 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
532 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24.3
533 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54.9
534 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24.7
535 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65.9
536 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18.8
537 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34.4
538 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1.6
539 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14.10
540 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54.10
541 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16.9
542 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34.5
543 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26.1
544 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11.2
545 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8.4
546 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Olsztyn 60.10
547 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 23.6
548 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12.6
549 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
550 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2.1
551 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24.1
552 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8.3
553 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
554 cord tissue (Wharton's jelly) birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11/12
555 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4.10
556 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15.10
557 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18.9
558 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2.1
559 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3.5
560 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3.5
561 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18.8
562 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17.5
563 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19.7
564 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7.1
565 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4.3
566 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17.2
567 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 65
568 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 47
569 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 60
570 peripheral blood T-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Australia 30
571 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Austria 54
572 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Belgium 57
573 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 19
574 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 71
575 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 34
576 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 55
577 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Belgium 38
578 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 12
579 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 57
580 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 56
581 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 67
582 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 63
583 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Croatia 64
584 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 48
585 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 62
586 peripheral blood Langerhans Lymphohistiocytosis hematology 2017 standard therapy Czech Republic 2
587 peripheral blood myelofibrosis hematology 2017 standard therapy Denmark 63
588 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Estonia 67
589 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 46
590 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 68
591 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 65
592 peripheral blood no data n/a 2017 standard therapy France 39
593 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 43
594 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 56
595 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 75
596 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 56
597 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44
598 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology 2017 standard therapy Germany 29
599 peripheral blood Common variable immunodeficiency, relapsed hemophagocytic syndrome hematology 2017 standard therapy Germany 44
600 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 47
601 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 66
602 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 64
603 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
604 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 53
605 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 67
606 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Germany 56
607 peripheral blood acute myelogenous leukemia with myelodysplastic syndrome hematology 2017 standard therapy Germany 64
608 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 29
609 peripheral blood diffuse large B-cell lymphoma hematology 2017 standard therapy Germany 61
610 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 56
611 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 54
612 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
613 peripheral blood B-cell Chronic lymphoblastic leukemia hematology 2017 standard therapy Germany 48
614 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
615 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 47
616 peripheral blood β - Thalassemia Major hematology 2017 standard therapy India 4
617 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Iran 17
618 peripheral blood osteopetrosis hematology 2017 standard therapy Israel 3
619 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
620 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
621 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 61
622 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 45
623 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 58
624 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 32
625 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 55
626 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 39
627 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Lithuania 59
628 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 65
629 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 75
630 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 66
631 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 57
632 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60
633 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 43
634 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 14
635 peripheral blood Niemann–Pick disease hematology 2017 standard therapy Poland 2
636 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 3
637 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 54
638 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 3
639 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 46
640 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
641 peripheral blood no data hematology 2017 standard therapy Poland 39
642 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 64
643 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Poland 47
644 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
645 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
646 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 59
647 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 62
648 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 59
649 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 53
650 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 35
651 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 32
652 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Slovakia 64
653 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Slovakia 54
654 peripheral blood follicular CA hematology 2017 standard therapy South Africa 42
655 peripheral blood myelofibrosis hematology 2017 standard therapy Spain 63
656 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Spain 20
657 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 63
658 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Switzerland 75
659 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy Turkey 29
660 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 46
661 peripheral blood aplastic anaemia hematology 2017 standard therapy United Kingdom 23
662 peripheral blood myelofibrosis hematology 2017 standard therapy United Kingdom 55
663 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2
664 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy United Kingdom 51
665 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 24
666 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 63
667 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 56
668 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 75
669 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
670 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 44
671 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 53
672 peripheral blood hemophagocytosis hematology 2017 standard therapy USA 52
673 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 45
674 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 65
675 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
676 peripheral blood chłoniak nieziarniczy hematology 2017 standard therapy USA 42
677 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
678 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 33
679 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 69
680 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
681 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 70
682 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
683 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 67
684 peripheral blood other myleofibrosis hematology 2017 standard therapy USA 71
685 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 64
686 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
687 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 54
688 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 23
689 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 65
690 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 35
691 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 59
692 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
693 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
694 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
695 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
696 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
697 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
698 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
699 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
700 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
701 peripheral blood no data n/a 2016 standard therapy Belgium 30
702 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
703 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
704 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
705 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
706 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44
707 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
708 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
709 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
710 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47
711 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
712 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
713 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
714 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
715 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
716 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
717 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
718 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
719 peripheral blood myelodysplastic syndrome - RCMD hematology 2016 standard therapy Czech Republic 32
720 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
721 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
722 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
723 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
724 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
725 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
726 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
727 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
728 peripheral blood no data n/a 2016 standard therapy France 59
729 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
730 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
731 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
732 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
733 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
734 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
735 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
736 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
737 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
738 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
739 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
740 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
741 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56
742 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54
743 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35
744 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
745 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
746 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
747 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
748 peripheral blood no data n/a 2016 standard therapy Germany 71
749 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
750 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
751 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
752 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
753 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
754 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
755 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
756 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55
757 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
758 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
759 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
760 peripheral blood no data n/a 2016 standard therapy Germany 17
761 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
762 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
763 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
764 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
765 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
766 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
767 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
768 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
769 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
770 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
771 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
772 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
773 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
774 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
775 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
776 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
777 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
778 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63
779 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40
780 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15
781 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37
782 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
783 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51
784 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33
785 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59
786 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67
787 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
788 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66
789 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
790 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
791 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9
792 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
793 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
794 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
795 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
796 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
797 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
798 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
799 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
800 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
801 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
802 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
803 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30
804 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58
805 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21
806 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63
807 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
808 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
809 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
810 peripheral blood no data n/a 2016 standard therapy Netherlands 70
811 peripheral blood no data n/a 2016 standard therapy Netherlands 69
812 peripheral blood no data n/a 2016 standard therapy Netherlands 58
813 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
814 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
815 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39
816 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
817 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
818 peripheral blood no data n/a 2016 standard therapy Poland 43
819 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
820 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
821 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
822 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
823 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
824 peripheral blood no data n/a 2016 standard therapy Poland 28
825 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
826 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
827 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
828 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
829 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56
830 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
831 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
832 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
833 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
834 peripheral blood no data n/a 2016 standard therapy Poland 55
835 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
836 peripheral blood no data n/a 2016 standard therapy Poland 44
837 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
838 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
839 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
840 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
841 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
842 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58
843 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
844 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24
845 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55
846 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
847 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19
848 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
849 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
850 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
851 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
852 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44
853 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32
854 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18
855 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
856 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
857 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
858 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
859 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
860 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
861 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
862 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50
863 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
864 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
865 peripheral blood no data n/a 2016 standard therapy Sweden 58
866 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 0.7
867 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
868 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
869 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
870 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
871 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
872 peripheral blood no data n/a 2016 standard therapy Turkey 4
873 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
874 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
875 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
876 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
877 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
878 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
879 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
880 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
881 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
882 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68
883 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47
884 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61
885 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69
886 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 13
887 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Austria 3
888 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Canada 1
889 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 68
890 bone marrow hyper IgM syndrome hematology 2017 standard therapy Finland 2
891 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76
892 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 65
893 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 14
894 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Italy 60
895 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 38
896 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 59
897 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 10
898 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 55
899 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Lithuania 1
900 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6
901 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2
902 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 4
903 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 16
904 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Russia 30
905 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 59
906 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 1
907 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22
908 bone marrow severe combined immunodeficiency hematology 2017 standard therapy Turkey 6
909 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 2
910 bone marrow thalassemia major hematology 2017 standard therapy Turkey 11
911 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 10
912 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 9
913 bone marrow myelodysplastic syndrome hematology 2017 standard therapy USA 61
914 bone marrow leukemia hematology 2017 standard therapy USA 40
915 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 67
916 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 21
917 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 57
918 bone marrow pure red cell aplasia hematology 2017 standard therapy USA 5
919 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 60
920 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15
921 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
922 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20
923 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
924 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
925 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
926 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
927 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
928 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33
929 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9
930 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
931 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45
932 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
933 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
934 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
935 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
936 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
937 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12
938 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2
939 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3
940 bone marrow anaemia hematology 2016 standard therapy Germany 16
941 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6
942 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
943 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
944 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39
945 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
946 bone marrow no data n/a 2016 standard therapy Italy 3
947 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
948 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
949 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
950 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
951 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
952 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
953 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46
954 bone marrow anaemia hematology 2016 standard therapy Italy 5
955 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
956 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
957 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
958 bone marrow no data n/a 2016 standard therapy Poland 7
959 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Poland 0.6
960 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
961 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
962 bone marrow no data n/a 2016 standard therapy Poland 33
963 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22
964 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18
965 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
966 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
967 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
968 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
969 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
970 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
971 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}